AVROXA

Technologiepark-Zwijnaarde 82
9052 Gent
BE
AVROXA
Foundation date
10/01/2018
Sector
#Medical TechnologySubsector
- #Medtech - Biomaterials
- #Medtech - Coatings
- #Medtech - Delivery devices
- #Medtech - Diagnostic devices
- #Medtech - Non-active implantable devices
- #Medtech - Regenerative Medicine
AVROXA is a research and manufacturing company committed to the development of innovative solutions based on our versatile proprietary polymer platform technology of poly(2-oxazoline)s (abbreviated as POZ, PAOx,POX). We develop a vast range of high-quality, well-defined, ultra-pure poly(2-oxazoline)s under the brandname ULTROXA(R) for applications in therapeutics, drug delivery, biomaterials and diagnostics.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Celyad Oncology appoints Georges Rawadi as its new CEO
Tuesday March 28th 2023
Read more
-
BioLizard appoints Paul Vauterin as Chief Technology Officer
Monday March 27th 2023
Read more
-
ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI
Monday March 27th 2023
Read more
Jobs
More jobs-
-
28/03/23
East Flanders
Postdoc researcher: Unravelling proteostasis machineries in jasmonate signalling in tomato
Permanent
VIB -
28/03/23
East Flanders
PhD student: Phosphoregulation in jasmonate-mediated plant stress responses
Permanent
VIB